277 related articles for article (PubMed ID: 22767217)
1. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
2. The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.
Shen Z; Yang ZF; Gao Y; Li JC; Chen HX; Liu CC; Poon RT; Fan ST; Luk JM; Sze KH; Li TP; Gan RB; He ML; Kung HF; Lin MC
Cancer Res; 2008 Jan; 68(2):404-14. PubMed ID: 18199534
[TBL] [Abstract][Full Text] [Related]
3. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
[TBL] [Abstract][Full Text] [Related]
4. AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
Nie B; Shen Z; Wen JB; Wong OG; Hsueh WD; Huo LF; Kung HF; Jiang B; Lin MC
Mol Cancer Ther; 2008 Sep; 7(9):2855-65. PubMed ID: 18790766
[TBL] [Abstract][Full Text] [Related]
5. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R
Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538
[TBL] [Abstract][Full Text] [Related]
6. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
Sun P; Liu Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
[TBL] [Abstract][Full Text] [Related]
7. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
9. Regulation of MAP kinase by the BMP-4/TAK1 pathway in Xenopus ectoderm.
Goswami M; Uzgare AR; Sater AK
Dev Biol; 2001 Aug; 236(2):259-70. PubMed ID: 11476570
[TBL] [Abstract][Full Text] [Related]
10. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.
Kim SI; Kwak JH; Zachariah M; He Y; Wang L; Choi ME
Am J Physiol Renal Physiol; 2007 May; 292(5):F1471-8. PubMed ID: 17299140
[TBL] [Abstract][Full Text] [Related]
13. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
[TBL] [Abstract][Full Text] [Related]
14. SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.
Sreekanth GP; Chuncharunee A; Sirimontaporn A; Panaampon J; Noisakran S; Yenchitsomanus PT; Limjindaporn T
PLoS One; 2016; 11(2):e0149486. PubMed ID: 26901653
[TBL] [Abstract][Full Text] [Related]
15. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
16. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
17. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.
de Olano N; Koo CY; Monteiro LJ; Pinto PH; Gomes AR; Aligue R; Lam EW
Mol Cancer Res; 2012 Sep; 10(9):1189-202. PubMed ID: 22802261
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
19. HGFK1 is associated with a better prognosis and reverses inhibition by gefitinib in NSCLC cases.
Zhou XH; Tang LN; Yue L; Min DL; Yang Y; Huang JA; Shen Z
Asian Pac J Cancer Prev; 2012; 13(4):1457-61. PubMed ID: 22799348
[TBL] [Abstract][Full Text] [Related]
20. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Kumar B; Koul S; Petersen J; Khandrika L; Hwa JS; Meacham RB; Wilson S; Koul HK
Cancer Res; 2010 Jan; 70(2):832-41. PubMed ID: 20068172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
